| Literature DB >> 31426572 |
David Reinedahl1, Silvia Galli2, Tomas Albrektsson2,3, Pentti Tengvall3, Carina B Johansson4, Petra Hammarström Johansson4, Ann Wennerberg4.
Abstract
The clinical value of ligature-induced experimental peri-implantitis studies has been questioned due to the artificial nature of the model. Despite repeated claims that ligatures of silk, cotton and other materials may not induce bone resorption by themselves; a recent review showed that the tissue reaction toward them has not been investigated. Hence, the current study aimed to explore the hard and soft tissue reactions toward commonly used ligature materials. A total of 60 dental implants were inserted into the femur (n = 20) and tibia (n = 40) of 10 rabbits. The femoral implants were ligated with sterile 3-0 braided silk in one leg and sterile cotton retraction chord in the other leg. The tibial implants were ligated with silk or left as non-ligated controls. All wounds were closed in layers. After a healing time of 8 weeks, femoral (silk versus cotton) and proximal tibial (silk versus non-ligated control) implants were investigated histologically. Distal tibial (silk versus non-ligated control) implants were investigated with real time polymerase chain reaction (qPCR). The distance from the implant-top to first bone contact point was longer for silk ligated implants compared to non-ligated controls (p = 0.007), but did not vary between cotton and silk. The ligatures triggered an immunological reaction with cell infiltrates in close contact with the ligature materials, adjacent soft tissue encapsulation and bone resorption. qPCR further demonstrated an upregulated immune response toward the silk ligatures compared to non-ligated controls. Silk and cotton ligatures provoke foreign body reactions of soft tissue encapsulation type and bone resorption around implants in the absence of plaque.Entities:
Keywords: aseptic loosening; dental implant; ligature induced peri-implantitis; marginal bone loss; osseointegration
Year: 2019 PMID: 31426572 PMCID: PMC6723089 DOI: 10.3390/jcm8081248
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Schematic drawing of implant and ligature placement.
Figure 2(a) Ligature tied around the implant neck after half-way insertion of the implant. (b) Ligature compressed against the bone by finishing the implant insertion. (c) Wound closure with interrupted resorbable sutures in a layered fashion.
Gene sequences and biological entity.
| Primer | Forward Sequence | Reverse Sequence | Accession Number | Biological Entity |
|---|---|---|---|---|
| ACTβ | GAGATGCCATGTGACGGAAG | TTACACAAATGCGATGCTGC | NM_001101683.1 | Reference gene |
| ALPL | ACTGTGGACTACCTCTTG | GGTCAGTGATGTTGTTCC | XM_017346489 | Bone mineralization |
| ARG1 | GGATCATTGGAGCCCCTTTCTC | TCAAGCAGACCAGCCTTTCTC | NM_001082108.1 | M2 macrophage |
| C5aR1 | ACGTCAACTGCTGCATCAACC | AGGCTGGGGAGAGACTTGC | NM_017338812.1 | The complement system |
| CD11β | TTCAACCTGGAGACTGAGAACAC | TCAAACTGGACCACGCTCTG | XM_008248697.2 | M1 macrophage |
| CD19 | GGATGTATGTCTGTCGCCGT | AAGCAAAGCCACAACTGGAA | NM_002711879.3 | B lymphocytes |
| CD4 | CAACTGGAAACATGCGAACCA | TTGATGACCAGGGGGAAAGA | NM_008254148.2 | T lymphocytes |
| CD8 | GGCGTCTACTTCTGCATGACC | GAACCGGCACACTCTCTTCT | NM_008254148.2 | T lymphocytes |
| GAPDH | CCGAGACACGATGGTGAAGG | TGTAGACCATGTAGTGGAGGTCA | NM_001082253.1 | Reference gene |
| IL8 | CTTTTTGCCCTGACCATGCC | TCCTTCACAAGCGAGACCAC | NM_001171082.1 | Macrophage |
| LDHA | ACAAGTGCACAAACAAGTGGT | AGAGCCCCTTAAGCATGGTG | NM_001082277 | Reference gene |
| MCP1 | GCTCATAGCAGTCGCCTTCA | CATGAAGATCACAGCTTCTTTGGG | NM_001082294 | Macrophage fusion |
| NCF1 | TTCATCCGCCACATTGCCC | GTCCTGCCACTTCACCAAGA | XM_001082102.1 | Neutrophil |
| OC | AGAGTCTGGCAGAGGCTCAG | TCGCTTCACCACCTCGCT | XM_002715383 | Bone mineralization |
| CTSK | ACTCTGAAGATGCCTACCCCT | TTCAGGGCTTTCTCATTCCCC | NM_001082641 | Bone resorption |
| FGF2 | ATCTACACTGTGGAGCTTGCAG | TCATGCGGTCACACACTTCC | XM_002711077 | Fibroblast |
| IL1β | TCCTTGGTGTTGTCTGGCAC | GGCCACAGGTATCTTGTCGTT | NM_001082201 | M1 macrophage |
| IL6 | GAGGAAAGAGATGTGTGACCAT | AGCATCCGTCTTCTTCTATCAG | NM_001082064 | M1 macrophage |
| VEGFα | CTTGGGTGCATTGGAGCCTT | CTTCACCACTTCGTGGGGTTTA | XM_017345155 | Endothelial cells |
| TNFα | CTCTTTCCTGCTCGTGGCTG | GGAGGTTGTTTGGGGACTCTT | NM_001082263 | M1 Macrophage |
| TRAP | CTGGGTTTGCAGGAGTTG | TTGAAGAGCAGCGACAGA | NM_001081988 | Bone resorption |
ACTβ, β-actin (reference gene); ALPL, alkaline phosphatase; ARG1, arginase 1; C5aR1, complement C5a Receptor 1; CD11β, macrophage marker CD11β; CD19, B-lymphocyte surface protein CD19; CD4, T-cell surface glycoprotein CD4; CD8, T-cell transmembrane glycoprotein CD8; GAPDH, glyceraldehyde 3-phosphate dehydrogenase (reference gene); IL8, interleukin 8 receptor alpha; LDHA, lactate dehydrogenase A (reference gene); MCP1, monocyte chemotactic and activating factor; NCF1, neutrophil cytosolic factor; OC, osteocalcin; CTSK, Cathepsin K; FGF2, fibroblast growth factor 2; IL1β, interleukin 1 beta; IL6, interleukin 6; VEGFα, vascular endothelial growth factor alpha; TNFα, tumor necrosis factor alpha; TRAP, Triiodothyronine receptor auxiliary protein.
Figure 3(a) The soft tissue covering a tibial control implant (superior) and test implant (inferior) after removal of skin and subcutaneous tissues. (b) A small saucerization-like defect (green arrow) visible after removal of the silk ligature around the inferior implant and callus formation (black arrow) around the superior control implant.
Figure 4Box-plot showing the distance from implant top to first bone-to-implant contact for implants with silk ligatures (Silk) and pristine implants (Control).
Figure 5(a) A typical example of a control sample (no ligature involved) with darker stained periosteal and endosteal new bone formation. (b) This figure illustrates seemingly an ongoing bone remodeling region with clear demarcation between old bone (lighter stained) and younger bone (larger osteocytes and a bit darker stained bone tissue). Possibly some macrophages can be observed in the region closer to the implant.
Figure 6Sample figures from different silk sections. (a) Survey figure of a typical section with a silk ligature (arrows) above a partly resorbed cortical bone surface in the periosteal region. (b) In some cases, the silk ligatures (in close contact to the implant) were surrounded by a thick cellular infiltrate layer (arrows) dominated by macrophages of various sizes and shapes. Outside this formation, loose connective tissue was formed. (c) The same section in higher resolution. (d) This figure illustrates a rather large “dome-like” callus formation of the periosteal bone and it seems like the implant part above the silk ligature is almost covered by new formed bone. (e) The arrows illustrate a large, elongated multinucleated giant cell (MNGC) in intimate contact with the silk.
Figure 7Three images from one cotton section with arrows showing the cotton ligature. (a) An illustration of a typical section with cotton suture situated above the periosteal bone. (b) The periosteal bone surface is separated from the cotton ligature by a soft tissue layer and the bone surface appears to be resorbed (arrows), although no osteoclasts could be observed. (c) The amount of macrophages in the soft tissue between the bone and the cotton seemed to be less compared to the silk sections. However, macrophages were visible as being more spread out and “darker” compared to silk samples. None of the cotton samples demonstrated a typical MNGC formation and the “encapsulation” of cotton was often loosely arranged (arrows).
Relative expression of the selected gene targets in the soft tissues around implants with silk ligature versus the soft tissues around controls (no ligature involved).
| Target Gene | Relative Expression in Test versus Control | 95% CI Low | 95% CI High | |
|---|---|---|---|---|
| NCF1 | 4.9 | 1.9 | 12.4 | 0.008 |
| CD11β | 2.8 | 1.5 | 5.4 | 0.016 |
| CD4 | 2.3 | 1.7 | 3.1 | 0.016 |
| VEGFα | 1.6 | 1.0 | 2.5 | 0.05 |
| TNFα | 1.7 | 0.9 | 2.9 | 0.08 |
| ARG1 | 2.4 | 0.9 | 6.5 | 0.11 |
| IL8 | 0.5 | 0.2 | 1.2 | 0.11 |
| FGF2 | 0.8 | 0.5 | 1.2 | 0.11 |
| CD8 | 3.9 | 0.5 | 27.4 | 0.22 |
| CD19 | 2.1 | 0.5 | 12.3 | 0.22 |
| OC | 1.7 | 0.7 | 4.2 | 0.25 |
| C5aR1 | 1.3 | 0.9 | 2.0 | 0.31 |
| TRAP | 1.7 | 0.5 | 5.4 | 0.37 |
| IL1β | 0.7 | 0.2 | 2.5 | 0.58 |
| IL6 | 0.8 | 0.3 | 2.5 | 0.58 |
| ALPL | 1.2 | 0.5 | 3.1 | 0.64 |
| MCP1 | 0.9 | 0.3 | 2.8 | 0.84 |
| CTSK | 1.0 | 0.7 | 1.5 | 0.84 |
CI = confidence interval. p-value was calculated with Wilcoxon Signed Rank test, significance level was set to p ≤ 0.0027 after Bonferroni´s adjustment for multiple testing. No gene showed significant difference in expression.
Figure 8Up and down regulation of the selected markers in the soft tissues around implants with silk ligatures versus controls (no ligature).
Relative expression of the selected gene targets in the bone around implants with silk ligature versus the bone around controls (no ligature).
| Target Gene | Relative Expression in Test versus Control | 95% CI Low | 95% CI High | |
|---|---|---|---|---|
| IL6 | 0.1 | 0.0 | 0.9 | 0.04 |
| CTSK | 0.7 | 0.5 | 1.0 | 0.04 |
| OC | 0.6 | 0.4 | 1.1 | 0.07 |
| NCF1 | 3.5 | 0.8 | 15.2 | 0.07 |
| MCP1 | 2.2 | 0.8 | 5.9 | 0.08 |
| CD19 | 2.7 | 0.6 | 12.3 | 0.13 |
| CD11β | 2.6 | 0.6 | 12.2 | 0.14 |
| TNFα | 0.4 | 0.1 | 2.3 | 0.19 |
| FGF2 | 0.6 | 0.2 | 1.6 | 0.19 |
| IL1β | 2.1 | 0.5 | 8.8 | 0.19 |
| IL8 | 0.5 | 0.1 | 2.4 | 0.26 |
| C5aR1 | 1.9 | 0.4 | 9.3 | 0.28 |
| CD4 | 2.6 | 0.3 | 25.0 | 0.28 |
| CD8 | 1.4 | 0.4 | 5.2 | 0.42 |
| TRAP | 2.2 | 0.1 | 40.0 | 0.46 |
| VEGFα | 1.8 | 0.2 | 20.4 | 0.49 |
| ALPL | 0.8 | 0.2 | 4.4 | 0.76 |
CI = confidence interval. p-value calculated with Wilcoxon Signed Rank test, significance level was set to p ≤ 0.0027 after Bonferroni´s adjustment for multiple testing. No gene showed significant difference in expression.
Figure 9Up and down regulation of the selected markers in the bone around implants with silk ligatures versus controls (no ligature).